AI-enhanced remote IV monitoring market seen doubling by 2030

The market for AI-enhanced remote patient intravenous monitoring is projected to grow from $1.69 billion in 2025 to $4.45 billion by 2030, driven by telehealth, wearable devices and rising healthcare spending. North America leads today, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - AI-enhanced remote IV monitoring is becoming a larger part of digital care as providers look for better patient safety, earlier complication detection and more efficient infusion management. - The market’s projected jump from $1.69 billion in 2025 to $4.45 billion by 2030 signals strong demand for remote, data-driven tools in hospitals, outpatient settings and home-based care.

What happened: - The Business Research Company released its Global Market Report 2026 on the AI-enhanced remote patient intravenous monitoring market. - The report estimates the market will grow from $1.69 billion in 2025 to $2.05 billion in 2026. - The report forecasts the market will reach $4.45 billion by 2030. - The report links the market’s growth to broader adoption of AI-enabled infusion monitoring, telehealth, wearable health devices and higher healthcare spending.

The details: - AI-enhanced remote patient IV monitoring systems use AI algorithms to track IV therapy data in real time. - The systems are designed to detect irregularities, predict complications and optimize fluid or medication delivery for individual patients. - The technology combines sensors, data analytics and automated alerts to improve safety and efficiency across care settings. - The market grew in the past period because of wider use of IV therapies, more infusion-related complications, adoption of advanced patient monitoring systems, growth in smart infusion devices and tighter medication safety protocols. - The report says future growth will be supported by stronger predictive analytics, deeper integration of connected infusion systems and more remote clinical monitoring. - Expected trends include real-time IV flow analytics, AI-driven infusion error detection, smart infusion sensor technologies and stronger patient safety and compliance measures. - The report says telehealth has been a major catalyst because remote care platforms make continuous supervision and intervention easier for patients receiving IV therapy. - FAIR Health reported a 7.3% increase in national telehealth usage in 2023, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. - Wearable devices such as smartwatches and fitness trackers are also supporting the market by collecting continuous physiological data that can help flag abnormalities and guide interventions. - The UK Parliament’s House of Commons Library said NIHR and UK Research and Innovation invested around $15 million (£11.5 million) in wearable-technology research projects between 2023 and 2024. - Rising healthcare expenditure is another growth driver because it supports digital infrastructure, technology development and staff training. - The Centers for Medicare & Medicaid Services said U.S. national health expenditures rose 7.5% to $4.9 trillion in 2023, equal to $14,570 per person and 17.6% of GDP. - Medicare spending rose 8.1% to $1.0298 trillion, or 21% of total health spending. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The market is being pulled by two shifts at once: more care moving outside traditional hospitals and more devices generating live clinical data. - AI adds value when it can turn that data into alerts and predictions that reduce infusion errors and speed up intervention. - The regional outlook suggests mature health systems are adopting the technology first, while faster growth may come from markets expanding digital care capacity.

What's next: - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and market hotspot infographics. - More product development is likely around real-time analytics, connected infusion systems and remote monitoring workflows that fit telehealth and home care. - The company is also offering a free sample and the full report through its website.